comprehensive -WSS

comprehensive

author：knowledge 2025-08-12 08:29:37 - browse：7

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： Fauci’s Covid grilling leads GOP to weigh foreign research rules

explore

knowledge

WSS

New study raises questions about niacin and heart health

Health and fitness trackers are measuring the wrong things

Ukraine seeks to reclaim its role as a hub for clinical trials

Secretariat’s lessons for human medicine

In 'major milestone,' FDA approves first cell therapy for solid tumors

Idaho abortion case may prompt more restrictions in other states

hotspot

comprehensive

hotspot

Jerome Adams on the need for new antivirals for Covid

As JPM 2024 winds down, some health tech firms project optimism

Sports medicine is finally prioritizing gender equality

The nurse manager staffing crisis is hurting patients

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: live from JPM 2024

ChatGPT in medicine: STAT answers readers' burning questions

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

focus

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Opioid cravings were reduced by anti

Congress may force more Covid

Ukraine seeks to reclaim its role as a hub for clinical trials

Fauci’s Covid grilling leads GOP to weigh foreign research rules

explore

explore

knowledge

focus